EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Signaling pathways that regulate adaptive β‐cell proliferation for the treatment of diabetes

Jun Shirakawa iD

Journal of Diabetes Investigation · 2023

DOI: 10.1111/jdi.14002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Diabetes Investigation, 2023. Verfasst von Jun Shirakawa. Beteiligte Einrichtung: Laboratory of Diabetes and Metabolic Disorders, Institute for Molecular and Cellular Regulation (IMCR), Gunma University, Maebashi, Japan. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 2, Insulin-Secreting Cells. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AMED, Astellas Foundation for Research on Metabolic Disorders, Daiichi Sankyo Foundation of Life Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The decline in β‐cell mass due to the failure of β‐cell compensation is one cause of the development of type 2 diabetes. Therefore, elucidation of the mechanism by which an adaptive increase in β‐cell mass occurs in vivo will lead to the development of a cure for diabetes. Insulin and insulin receptor (IR)‐mediated signaling pathways play an important role in the mechanism that increases β‐cell mass by compensatory β‐cell proliferation in response to chronic insulin resistance. However, whether IR is required for compensatory β‐cell proliferation remains controversial in some situations. It might be possible that IR acts as a scaffold for the signaling complex independent of its ligand. It has also been reported that the forkhead box protein M1/polo‐like kinase 1/centromere protein A pathway plays a central role in adaptive β‐cell proliferation during diet‐induced obesity, hyperglycemia, pregnancy, aging and acute insulin resistance. We recently reported that the cross‐talk of islets with fat tissue, in addition to the liver, through humoral factors is involved in adaptive β‐cell proliferation. This accommodative response of β‐cell proliferation through adipocytes was observed particularly under an acute insulin resistance state in an IR/insulin signal‐independent and forkhead box protein M1/polo‐like kinase 1/centromere protein A pathway‐dependent manner. A remaining barrier for the treatment of human diabetes using β‐cells is the differences between human and rodent islets. In this review, the focus is on signaling pathways that regulate adaptive β‐cell proliferation for the treatment of diabetes considering the abovementioned issues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceDiabetes Mellitus, Type 2Insulin-Secreting CellsPregnancyFemaleHumansForkhead Box Protein M1Centromere Protein ASignal TransductionInsulinCell Proliferation

Stichwörter der Autor:innen

Beta cellsInsulin resistanceIslets

Substanzen

Forkhead Box Protein M1Centromere Protein AInsulin

Autor:innen und Institutionen

  • Laboratory of Diabetes and Metabolic Disorders, Institute for Molecular and Cellular Regulation (IMCR), Gunma University, Maebashi, Japan.
  • Department of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City University, Yokohama City, Japan.

ORCID-Profile: Jun Shirakawa

Förderung

  • AMED
  • Astellas Foundation for Research on Metabolic Disorders
  • Daiichi Sankyo Foundation of Life Science
  • Japan Agency for Medical Research and Development
  • Japan Diabetes Foundation
  • Japan Diabetes Society
  • Japan IDDM network
  • Manpei Suzuki Diabetes Foundation

Zitieren

APA

Shirakawa, J. (2023). Signaling pathways that regulate adaptive β‐cell proliferation for the treatment of diabetes. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14002

Vancouver

Shirakawa J. Signaling pathways that regulate adaptive β‐cell proliferation for the treatment of diabetes. Journal of Diabetes Investigation. 2023. doi:10.1111/jdi.14002

BibTeX
@article{Shirakawa2023,
  author = {Shirakawa, Jun},
  title = {Signaling pathways that regulate adaptive β‐cell proliferation for the treatment of diabetes},
  journal = {Journal of Diabetes Investigation},
  year = {2023},
  doi = {10.1111/jdi.14002}
}
Kostenlos starten →